Uncategorized

Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services

Zomedica Corp. announced today the launch of the revolutionary TRUVIEW TM digital microscopy platform, featuring the proprietary TRUprep TM system that automatically prepares slides, along with LiquiView TM liquid lens technology that provides best-in-class images.

Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services Read More »

Inteligencia artificial para hacer trabajos escolares, ¿el truco definitivo de los alumnos tramposos?

El debut del sistema de inteligencia artificial llamado ChatGPT, y en especial el de su última versión, no ha dejado de asombrar al mundo por su notable habilidad para elaborar textos coherentes e informativos sobre los temas que se le piden. La habilidad de esta inteligencia artificia …

Inteligencia artificial para hacer trabajos escolares, ¿el truco definitivo de los alumnos tramposos? Read More »

Invibio, Part of Victrex plc, Announces New Collaboration With Paragon Medical to Support Scale Up of PEEK Based Trauma Devices

Invibio Biomaterial Solutions, part of Victrex plc, a pioneer in the development of PEEK biomaterial solutions, announced a new collaboration with Paragon Medical, a medical device contract design manufacturer with over a century of combined expertise in high-precision manufacturing, advanced engineering and design support, to manufacture composite PEEK-OPTIMA™ Ultra-Reinforced medical trauma devices.

Invibio, Part of Victrex plc, Announces New Collaboration With Paragon Medical to Support Scale Up of PEEK Based Trauma Devices Read More »

Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress

Wugen, Inc. presented data for its two lead programs, WU-CART-007 and WU-NK-101, in separate presentations at the European Hematology Association 2023 Congress, taking place from June 8 – 11, 2023 in Frankfurt, Germany.

Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress Read More »

BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congress

BeiGene, a global biotechnology company, announced the presentation of new data from its broad blood cancer portfolio of approved therapies and promising early-stage pipeline products at the 2023 European Hematology Association Hybrid Congress.

BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congress Read More »

Scroll to Top